These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15279122)

  • 1. Pilot-testing a statewide outcome monitoring system: overview of the California Treatment Outcome Project (CALTOP).
    Evans E; Hser YI
    J Psychoactive Drugs; 2004 May; Suppl 2():109-14. PubMed ID: 15279122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the accountability of California's public substance abuse treatment system through the implementation of performance models.
    Rawson RA; Gonzales R; Crèvecoeur-MacPhail D; Urada D; Brecht ML; Chalk M; Kemp J; Cunningham M
    J Psychoactive Drugs; 2010 Sep; Suppl 6():211-4. PubMed ID: 21138197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client-service matching in substance abuse treatment for women with children.
    Smith BD; Marsh JC
    J Subst Abuse Treat; 2002 Apr; 22(3):161-8. PubMed ID: 12039620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices.
    Skelton E; Tzelepis F; Shakeshaft A; Guillaumier A; Dunlop A; McCrabb S; Palazzi K; Bonevski B
    J Subst Abuse Treat; 2017 Jun; 77():101-106. PubMed ID: 28476261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).
    Salomé HJ; French MT; Miller M; McLellan AT
    Drug Alcohol Depend; 2003 Aug; 71(2):195-206. PubMed ID: 12927658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workforce professionalism in drug treatment services: impact of California's Proposition 36.
    Wu F; Hser YI
    J Subst Abuse Treat; 2011 Jan; 40(1):44-55. PubMed ID: 21036513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing treatment access: evaluation of an Australian Web-based alcohol and drug counselling initiative.
    Swan AJ; Tyssen EG
    Drug Alcohol Rev; 2009 Jan; 28(1):48-53. PubMed ID: 19320675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and reporting alcohol and drug use trends in California: the California Substance Abuse Research Consortium meetings.
    Finnerty BA
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():119-25. PubMed ID: 12825754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding results from randomized trials: use of program- and client-level data to study medical and nonmedical treatment programs.
    Kaskutas LA; Ammon L; Witbrodt J; Graves K; Zemore S; Borkman T; Weisner S
    J Stud Alcohol; 2005 Sep; 66(5):682-7. PubMed ID: 16331853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inside the black box: measuring addiction treatment services and their relation to outcomes.
    Crèvecoeur-MacPhail D; Ransom L; Myers AC; Annon JJ; Diep N; Gonzales R; Rawson RA; Viemes J; Sugita W; Barger J
    J Psychoactive Drugs; 2010 Sep; Suppl 6():269-76. PubMed ID: 21138203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing indicators for emergency medical services (EMS) system evaluation and quality improvement: a statewide demonstration and planning project.
    Sobo EJ; Andriese S; Stroup C; Morgan D; Kurtin P
    Jt Comm J Qual Improv; 2001 Mar; 27(3):138-54. PubMed ID: 11242720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies.
    Greenfield L; Burgdorf K; Chen X; Porowski A; Roberts T; Herrell J
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):537-50. PubMed ID: 15540492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Client outcomes from rural substance abuse treatment.
    Hiller ML; Leukefeld CG; Garrity TF; Godlaski T; Schoeneberger M; Townsend M; Hascal K
    J Psychoactive Drugs; 2007 Mar; 39(1):59-68. PubMed ID: 17523586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for using standardized outcome measures following addictions treatment.
    Graham K
    Eval Health Prof; 1994 Mar; 17(1):43-59. PubMed ID: 10171802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a statewide outcome monitoring system: lessons learned from substance abuse treatment provider staff.
    Teruya C; Hardy M; Hser YI; Evans E
    Qual Health Res; 2006 Mar; 16(3):337-52. PubMed ID: 16449685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance improvement in addiction treatment: efforts in California.
    Herbeck DM; Gonzales R; Rawson RA
    J Psychoactive Drugs; 2010 Sep; Suppl 6():261-8. PubMed ID: 21138202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.